Praxis Precision Medicines Ownership | Who Owns Praxis Precision Medicines?


OverviewForecastFinancialsChartTranscripts

Praxis Precision Medicines Ownership Summary


Praxis Precision Medicines is owned by 30.27% institutional investors, 0.32% insiders, and 69.41% retail investors. Orbis allan gray is the largest institutional shareholder, holding 10.99% of PRAX shares. American Funds SMALLCAP World A is the top mutual fund, with 3.71% of its assets in Praxis Precision Medicines shares.

PRAX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPraxis Precision Medicines30.27%0.32%69.41%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbis allan gray2.47M10.99%$796.61M
Blackrock funding, inc. /de2.32M10.33%$749.07M
Fmr2.16M9.60%$696.23M
Perceptive advisors2.04M9.05%$655.97M
Baker bros. advisors lp1.75M7.79%$564.86M
Point72 asset management1.50M6.97%$79.29M
Vanguard group1.46M6.65%$430.60M
Deerfield management company, l.p. (series c)963.35K4.28%$310.38M
Driehaus capital management949.23K4.22%$305.83M
Cormorant asset management, lp885.50K3.93%$285.30M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
72 investment65.93K42.83%$21.24M
Velan capital investment management lp100.78K20.34%$32.47M
Acuta capital partners84.90K19.30%$27.35M
Cormorant asset management, lp885.50K14.33%$285.30M
Perceptive advisors2.04M12.83%$655.97M
Vivo capital338.89K9.11%$109.19M
Lion point capital, lp4.45K8.57%$1.43M
B group33.24K7.94%$10.71M
Exome asset management45.47K7.58%$14.65M
University of wisconsin foundation25.21K7.21%$8.12M

Top Buyers

HolderShares% AssetsChange
Orbis allan gray2.47M3.36%1.22M
Fmr2.16M0.04%802.27K
Baker bros. advisors lp1.75M3.24%626.71K
Point72 asset management1.50M0.13%541.91K
Blackrock funding, inc. /de2.32M0.01%246.43K

Top Sellers

HolderShares% AssetsChange
Janus henderson group84.95K0.01%-3.16M
Vr adviser---989.99K
Capital research global investors---853.75K
Barclays6.98K0.00%-523.77K
Assenagon asset management---408.79K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust169.90K0.01%169.90K$54.74M
Frontier capital management53.37K0.18%53.37K$17.19M
California public employees retirement system42.16K0.01%42.16K$13.58M
University of wisconsin foundation25.21K7.21%25.21K$8.12M
Vanguard asset management22.00K0.01%22.00K$7.09M

Sold Out

HolderChange
Marquette asset management-2.00
Creative financial designs inc /adv-6.00
Principal securities-6.00
Bellevue asset management-6.00
Assetmark-7.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026149-45.02%6,812,962-76.88%300.17%109-46.57%29-40.82%
Dec 31, 2025147-10.91%10,583,084-57.09%480.36%12638.46%19-55.81%
Sep 30, 20251598.16%24,489,0118.54%1141.03%884.76%4132.26%
Jun 30, 2025155-6.06%24,147,5133.31%1120.91%884.76%33-35.29%
Mar 31, 202516-90.86%7,276,078-66.50%340.26%10-89.47%3-94.12%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A748.24K3.71%-139.82K
Vanguard Total Stock Mkt Idx Inv887.68K3.18%2.21K
Vanguard US Total Market Shares ETF541.27K2.68%-
iShares Russell 2000 ETF607.25K2.18%5.12K
Orbis Global Equity Investor567.38K2.04%295.46K
Renaissance Global Health Care388.36K1.85%-
SPDR® S&P Biotech ETF302.24K1.44%675.00
Janus Henderson Global Life Sciences394.81K1.42%-38.95K
Janus Henderson Global Life Sciences D394.81K1.42%-21.72K
Fidelity Select Biotechnology388.90K1.40%-1.60K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 20, 2025Nemiroff Alex General Counsel and SecretarySell$188.79K
Nov 20, 2025Nemiroff Alex General Counsel and SecretarySell$1.77M
Nov 20, 2025Nemiroff Alex General Counsel and SecretarySell$327.14K
Nov 20, 2025Nemiroff Alex General Counsel and SecretarySell$2.57M
Nov 20, 2025Mastrocola Lauren Principal Accounting OfficerSell$2.20M

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1--
2025 Q4-16
2025 Q3--
2025 Q2--

PRAX Ownership FAQ


Who Owns Praxis Precision Medicines?

Praxis Precision Medicines shareholders are primarily institutional investors at 30.27%, followed by 0.32% insiders and 69.41% retail investors. The average institutional ownership in Praxis Precision Medicines's industry, Biotech Stocks , is 35.75%, which Praxis Precision Medicines falls below.

Who owns the most shares of Praxis Precision Medicines?

Praxis Precision Medicines’s largest shareholders are Orbis allan gray (2.47M shares, 10.99%), Blackrock funding, inc. /de (2.32M shares, 10.33%), and Fmr (2.16M shares, 9.60%). Together, they hold 30.92% of Praxis Precision Medicines’s total shares outstanding.

Does Blackrock own Praxis Precision Medicines?

BlackRock is not among the top 10 institutional shareholders of Praxis Precision Medicines.

Who is Praxis Precision Medicines’s biggest shareholder by percentage of total assets invested?

72 investment is Praxis Precision Medicines’s biggest shareholder by percentage of total assets invested, with 42.83% of its assets in 65.93K Praxis Precision Medicines shares, valued at 21.24M$.

Who is the top mutual fund holder of Praxis Precision Medicines shares?

American Funds SMALLCAP World A is the top mutual fund holder of Praxis Precision Medicines shares, with 3.71% of its total shares outstanding invested in 748.24K Praxis Precision Medicines shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools